A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions

A quantitative systems pharmacology (QSP) model of the pathogenesis and treatment of SARS-CoV-2 infection can streamline and accelerate the development of novel medicines to treat COVID-19. Simulation of clinical trials allows in silico exploration of the uncertainties of clinical trial design and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Rohit, Musante, Cynthia J., Allen, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102696/
https://www.ncbi.nlm.nih.gov/pubmed/37059734
http://dx.doi.org/10.1038/s41540-023-00269-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102696/
https://www.ncbi.nlm.nih.gov/pubmed/37059734
http://dx.doi.org/10.1038/s41540-023-00269-6

Ejemplares similares